Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cytoskeletal protein binding	ABLIM1 SLC8A1 MYH9 CALD1 MAP1A NF2 MICALL2 MYO6 SMC3 MYO7A GAS8 PKD2 DAAM2 AFDN CCDC181 NEXN MYO5C	1.41e-08	1099	60	17	GO:0008092
GeneOntologyMolecularFunction	actin binding	ABLIM1 MYH9 CALD1 MAP1A NF2 MICALL2 MYO6 MYO7A DAAM2 AFDN NEXN MYO5C	1.56e-08	479	60	12	GO:0003779
GeneOntologyMolecularFunction	actin filament binding	ABLIM1 MYH9 MICALL2 MYO6 MYO7A AFDN NEXN MYO5C	3.79e-07	227	60	8	GO:0051015
GeneOntologyMolecularFunction	microfilament motor activity	MYH9 MYO6 MYO7A MYO5C	5.04e-06	38	60	4	GO:0000146
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYH9 MYO6 SMC3 MYO7A MYO5C	2.79e-05	118	60	5	GO:0003774
GeneOntologyMolecularFunction	calmodulin binding	SLC8A1 MYH9 CALD1 MYO6 MYO7A MYO5C	6.52e-05	230	60	6	GO:0005516
GeneOntologyMolecularFunction	phosphatidylcholine transfer activity	PITPNA PITPNB	1.32e-04	6	60	2	GO:0120019
GeneOntologyMolecularFunction	ADP binding	MYH9 MYO6 MYO7A	4.05e-04	48	60	3	GO:0043531
GeneOntologyMolecularFunction	ATP-dependent activity	MYH9 MYO6 SMC3 MYO7A DHX38 SMC6 POLQ MYO5C	4.77e-04	614	60	8	GO:0140657
GeneOntologyMolecularFunction	phosphatidylinositol transfer activity	PITPNA PITPNB	4.80e-04	11	60	2	GO:0008526
GeneOntologyMolecularFunction	phosphatidylcholine transporter activity	PITPNA PITPNB	1.63e-03	20	60	2	GO:0008525
GeneOntologyBiologicalProcess	supramolecular fiber organization	MYH9 MIA3 CALD1 MAP1A NF2 MICALL2 MYO6 MYO7A BMERB1 MFN2 DAAM2 MYH16 MYO5C	4.26e-06	957	62	13	GO:0097435
GeneOntologyCellularComponent	myosin complex	MYH9 MYO6 MYO7A MYH16 MYO5C	8.62e-07	59	62	5	GO:0016459
GeneOntologyCellularComponent	actin cytoskeleton	ABLIM1 MYH9 CALD1 NF2 MICALL2 MYO6 MYO7A RAB22A MYH16 NEXN MYO5C	8.99e-07	576	62	11	GO:0015629
GeneOntologyCellularComponent	postsynaptic density	ABLIM1 SLC8A1 MAP1A LZTS3 MYO6 RNF112 AFDN EIF3A DGCR8	6.89e-06	451	62	9	GO:0014069
GeneOntologyCellularComponent	asymmetric synapse	ABLIM1 SLC8A1 MAP1A LZTS3 MYO6 RNF112 AFDN EIF3A DGCR8	1.08e-05	477	62	9	GO:0032279
GeneOntologyCellularComponent	postsynaptic specialization	ABLIM1 SLC8A1 MAP1A LZTS3 MYO6 RNF112 AFDN EIF3A DGCR8	1.64e-05	503	62	9	GO:0099572
GeneOntologyCellularComponent	neuron to neuron synapse	ABLIM1 SLC8A1 MAP1A LZTS3 MYO6 RNF112 AFDN EIF3A DGCR8	2.24e-05	523	62	9	GO:0098984
GeneOntologyCellularComponent	cell-cell junction	SLC8A1 MYH9 NF2 MICALL2 PKD2 SNAP23 AFDN NEXN WNK4	5.79e-05	591	62	9	GO:0005911
GeneOntologyCellularComponent	postsynapse	ABLIM1 SLC8A1 CALD1 MAP1A LZTS3 MYO6 RNF112 SNAP23 AFDN EIF3A DGCR8	1.79e-04	1018	62	11	GO:0098794
GeneOntologyCellularComponent	mitotic spindle pole	SMC3 MAD1L1 SMC6	2.82e-04	43	62	3	GO:0097431
GeneOntologyCellularComponent	contractile actin filament bundle	ABLIM1 MYH9 CALD1 MICALL2	2.88e-04	107	62	4	GO:0097517
GeneOntologyCellularComponent	stress fiber	ABLIM1 MYH9 CALD1 MICALL2	2.88e-04	107	62	4	GO:0001725
GeneOntologyCellularComponent	actomyosin	ABLIM1 MYH9 CALD1 MICALL2	4.05e-04	117	62	4	GO:0042641
GeneOntologyCellularComponent	adherens junction	MYH9 NF2 SNAP23 AFDN NEXN	4.14e-04	212	62	5	GO:0005912
GeneOntologyCellularComponent	actin filament bundle	ABLIM1 MYH9 CALD1 MICALL2	4.18e-04	118	62	4	GO:0032432
GeneOntologyCellularComponent	unconventional myosin complex	MYO6 MYO7A	4.68e-04	11	62	2	GO:0016461
GeneOntologyCellularComponent	cell cortex	MYH9 CALD1 NF2 MYO6 MYO7A PKD2	7.99e-04	371	62	6	GO:0005938
GeneOntologyCellularComponent	nuclear protein-containing complex	RTF1 SUPT3H MYH9 NOP14 ZMAT2 POLR2A DHX38 MAD1L1 BUD13 DGCR8 PDCD7	2.20e-03	1377	62	11	GO:0140513
GeneOntologyCellularComponent	anchoring junction	SLC8A1 MYH9 NF2 MICALL2 PKD2 SNAP23 AFDN NEXN WNK4	2.23e-03	976	62	9	GO:0070161
GeneOntologyCellularComponent	supramolecular fiber	SLC8A1 MYH9 CALD1 MAP1A MYO6 GAS8 STYXL2 EIF3A CCDC181 NEXN	2.31e-03	1179	62	10	GO:0099512
GeneOntologyCellularComponent	RNA polymerase II, holoenzyme	RTF1 SUPT3H POLR2A	2.35e-03	89	62	3	GO:0016591
GeneOntologyCellularComponent	supramolecular polymer	SLC8A1 MYH9 CALD1 MAP1A MYO6 GAS8 STYXL2 EIF3A CCDC181 NEXN	2.43e-03	1187	62	10	GO:0099081
GeneOntologyCellularComponent	cortical actin cytoskeleton	MYH9 CALD1 NF2	2.67e-03	93	62	3	GO:0030864
GeneOntologyCellularComponent	spindle	MYH9 MAP7D1 SMC3 MAD1L1 SMC6 PKD2	2.68e-03	471	62	6	GO:0005819
GeneOntologyCellularComponent	mitotic spindle	SMC3 MAD1L1 SMC6 PKD2	2.99e-03	201	62	4	GO:0072686
GeneOntologyCellularComponent	ruffle	MYH9 NF2 MYO6 RAB22A	3.27e-03	206	62	4	GO:0001726
GeneOntologyCellularComponent	site of double-strand break	SMC6 DGCR8 POLQ	3.37e-03	101	62	3	GO:0035861
GeneOntologyCellularComponent	cell leading edge	ABLIM1 MYH9 NF2 MYO6 RAB22A PKD2	3.60e-03	500	62	6	GO:0031252
GeneOntologyCellularComponent	spliceosomal complex	ZMAT2 DHX38 BUD13 PDCD7	3.81e-03	215	62	4	GO:0005681
GeneOntologyCellularComponent	nuclear DNA-directed RNA polymerase complex	RTF1 SUPT3H POLR2A	4.61e-03	113	62	3	GO:0055029
GeneOntologyCellularComponent	lamellipodium	ABLIM1 MYH9 NF2 PKD2	4.84e-03	230	62	4	GO:0030027
GeneOntologyCellularComponent	polymeric cytoskeletal fiber	SLC8A1 MYH9 CALD1 MAP1A MYO6 GAS8 EIF3A CCDC181	4.91e-03	899	62	8	GO:0099513
GeneOntologyCellularComponent	DNA-directed RNA polymerase complex	RTF1 SUPT3H POLR2A	4.96e-03	116	62	3	GO:0000428
GeneOntologyCellularComponent	RNA polymerase complex	RTF1 SUPT3H POLR2A	5.33e-03	119	62	3	GO:0030880
Domain	Myosin_head_motor_dom	MYH9 MYO6 MYO7A MYO5C	6.99e-06	38	61	4	IPR001609
Domain	MYOSIN_MOTOR	MYH9 MYO6 MYO7A MYO5C	6.99e-06	38	61	4	PS51456
Domain	Myosin_head	MYH9 MYO6 MYO7A MYO5C	6.99e-06	38	61	4	PF00063
Domain	MYSc	MYH9 MYO6 MYO7A MYO5C	6.99e-06	38	61	4	SM00242
Domain	P-loop_NTPase	MYH9 MYO6 SMC3 MYO7A RNF112 DHX38 RAB22A SMC6 MFN2 POLQ MYO5C	8.26e-05	848	61	11	IPR027417
Domain	IQ	MYH9 MYO6 MYO7A MYO5C	8.50e-05	71	61	4	PF00612
Domain	IP_trans	PITPNA PITPNB	1.04e-04	5	61	2	PF02121
Domain	IQ	MYH9 MYO6 MYO7A MYO5C	1.42e-04	81	61	4	SM00015
Domain	DIL	AFDN MYO5C	1.56e-04	6	61	2	PF01843
Domain	PI_transfer	PITPNA PITPNB	1.56e-04	6	61	2	IPR001666
Domain	Dilute_dom	AFDN MYO5C	1.56e-04	6	61	2	IPR002710
Domain	DILUTE	AFDN MYO5C	1.56e-04	6	61	2	PS51126
Domain	DIL	AFDN MYO5C	1.56e-04	6	61	2	SM01132
Domain	IQ_motif_EF-hand-BS	MYH9 MYO6 MYO7A MYO5C	2.13e-04	90	61	4	IPR000048
Domain	DUF3585	MICALL2 BMERB1	2.18e-04	7	61	2	IPR022735
Domain	DUF3585	MICALL2 BMERB1	2.18e-04	7	61	2	PF12130
Domain	IQ	MYH9 MYO6 MYO7A MYO5C	2.42e-04	93	61	4	PS50096
Domain	RecF/RecN/SMC_N	SMC3 SMC6	2.90e-04	8	61	2	IPR003395
Domain	SMC_N	SMC3 SMC6	2.90e-04	8	61	2	PF02463
Domain	Myosin_N	MYH9 MYO5C	1.07e-03	15	61	2	PF02736
Domain	Myosin_N	MYH9 MYO5C	1.07e-03	15	61	2	IPR004009
Domain	Myosin-like_IQ_dom	MYH9 MYO5C	1.73e-03	19	61	2	IPR027401
Domain	-	MYH9 MYO5C	1.73e-03	19	61	2	4.10.270.10
Domain	-	MAP1A ELAC2	1.92e-03	20	61	2	3.60.15.10
Domain	Metallo-B-lactamas	MAP1A ELAC2	1.92e-03	20	61	2	IPR001279
Domain	-	PITPNA PITPNB	2.54e-03	23	61	2	3.30.530.20
Domain	START-like_dom	PITPNA PITPNB	2.54e-03	23	61	2	IPR023393
Domain	-	SMC3 MYO7A RNF112 DHX38 RAB22A SMC6 MFN2 POLQ	2.83e-03	746	61	8	3.40.50.300
Domain	FERM_N	NF2 MYO7A	5.19e-03	33	61	2	PF09379
Domain	FERM_N	NF2 MYO7A	5.19e-03	33	61	2	IPR018979
Domain	t-SNARE	SNAP23 DAAM2	8.69e-03	43	61	2	IPR010989
Pathway	REACTOME_MRNA_SPLICING	RBM25 ZMAT2 POLR2A DHX38 BUD13 PDCD7	4.54e-05	201	46	6	MM15411
Pathway	REACTOME_MRNA_SPLICING	RBM25 ZMAT2 POLR2A DHX38 BUD13 PDCD7	6.11e-05	212	46	6	M14033
Pathway	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA	RBM25 ZMAT2 POLR2A DHX38 BUD13 PDCD7	2.64e-04	277	46	6	MM15414
Pathway	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA	RBM25 ZMAT2 POLR2A DHX38 BUD13 PDCD7	2.96e-04	283	46	6	M13087
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	PPP4R3B MYH9 RBM25 MIA3 CALD1 MYO6 SMC3 MYO7A PRRC2C EIF3A ELAC2 WNK4 YTHDF3	3.30e-09	847	63	13	35235311
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	RTF1 PPP4R3B MYH9 MAP7D1 RBM25 MYO6 SMC3 POLR2A DHX38 PITPNA GAS8 AFDN EIF3A POLQ ELAC2	6.88e-09	1284	63	15	17353931
Pubmed	Identification and overlapping expression of multiple unconventional myosin genes in vertebrate cell types.	MYH9 MYO6 MYO7A MYO5C	9.65e-09	14	63	4	8022818
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	ABLIM1 SUPT3H MAP7D1 NOP14 MICALL2 POLR2A DHX38 RAB22A SNAP23 BUD13 AFDN EIF3A DGCR8 PDCD7 CEP164	5.24e-08	1497	63	15	31527615
Pubmed	Assessment of myosin II, Va, VI and VIIa loss of function on endocytosis and endocytic vesicle motility in bone marrow-derived dendritic cells.	MYH9 MYO6 MYO7A	5.65e-08	5	63	3	17615572
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	MYH9 RBM25 PRRC2C POLR2A AFDN EIF3A NEXN	8.44e-08	202	63	7	24639526
Pubmed	UM171 Preserves Epigenetic Marks that Are Reduced in Ex Vivo Culture of Human HSCs via Potentiation of the CLR3-KBTBD4 Complex.	MYH9 MIA3 MYO6 SMC3 AFDN EIF3A ANKRD40	5.57e-07	267	63	7	33417871
Pubmed	Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration.	ABLIM1 MAP7D1 MAP1A NF2 MYO6 RAB22A AFDN EIF3A DGCR8	7.24e-07	558	63	9	35063084
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	MYH9 MAP7D1 NOP14 UBE4B MYO6 SMC3 POLR2A DHX38 AFDN EIF3A NEXN ELAC2 NMD3	7.54e-07	1353	63	13	29467282
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	ABLIM1 MYH9 RBM25 CALD1 NF2 MYO6 SMC3 TNIP1 EIF3A NEXN MYO5C	9.93e-07	949	63	11	36574265
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	RTF1 PPP4R3B MYH9 RBM25 SMC3 POLR2A DHX38 MAD1L1 SMC6 EIF3A ELAC2	1.89e-06	1014	63	11	32416067
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	RTF1 ABLIM1 MAP1A NF2 POLR2A NEXN ELAC2 YTHDF3	2.19e-06	472	63	8	38943005
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	NOP14 UBE4B POLR2A DHX38 MAD1L1 SMC6 KAT6B	2.83e-06	341	63	7	32971831
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	PPP4R3B ABLIM1 NF2 UBE4B MYO6 NUCB1 SESN3 MAP3K10 DAAM2 AFDN DGCR8 PDCD7	2.87e-06	1285	63	12	35914814
Pubmed	Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multiprotein networks.	MIA3 LZTS3 POLR2A MYH16 EIF3A PDCD7	3.01e-06	220	63	6	24550385
Pubmed	Nuclear myosin VI enhances RNA polymerase II-dependent transcription.	MYO6 POLR2A	3.23e-06	2	63	2	16949370
Pubmed	Biochemical and biological functions of class I phosphatidylinositol transfer proteins.	PITPNA PITPNB	3.23e-06	2	63	2	17490911
Pubmed	Specific and nonspecific membrane-binding determinants cooperate in targeting phosphatidylinositol transfer protein beta-isoform to the mammalian trans-Golgi network.	PITPNA PITPNB	3.23e-06	2	63	2	16540520
Pubmed	Biological functions of phosphatidylinositol transfer proteins.	PITPNA PITPNB	3.23e-06	2	63	2	15052341
Pubmed	Structure of PITPbeta in complex with phosphatidylcholine: comparison of structure and lipid transfer to other PITP isoforms.	PITPNA PITPNB	3.23e-06	2	63	2	16274224
Pubmed	Genetic ablation of phosphatidylinositol transfer protein function in murine embryonic stem cells.	PITPNA PITPNB	3.23e-06	2	63	2	11907258
Pubmed	Polycystin 2 regulates mitochondrial Ca2+ signaling, bioenergetics, and dynamics through mitofusin 2.	PKD2 MFN2	3.23e-06	2	63	2	31064883
Pubmed	Cloning and expression of human cDNA encoding phosphatidylinositol transfer protein beta.	PITPNA PITPNB	3.23e-06	2	63	2	8541325
Pubmed	Phospholipid transfer proteins.	PITPNA PITPNB	3.23e-06	2	63	2	1883207
Pubmed	Dynamics of lipid transfer by phosphatidylinositol transfer proteins in cells.	PITPNA PITPNB	3.23e-06	2	63	2	18636990
Pubmed	Schwannomin inhibits tumorigenesis through direct interaction with the eukaryotic initiation factor subunit c (eIF3c).	NF2 EIF3A	3.23e-06	2	63	2	16497727
Pubmed	An isoform of the phosphatidylinositol-transfer protein transfers sphingomyelin and is associated with the Golgi system.	PITPNA PITPNB	3.23e-06	2	63	2	7654206
Pubmed	Ubiquitin-Activated Interaction Traps (UBAITs) identify E3 ligase binding partners.	MYO6 SMC3 POLR2A EIF3A	5.04e-06	62	63	4	26508657
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	MAP7D1 CALD1 MAP1A NF2 MYO6 PRRC2C ZMAT2 SMC6 YTHDF3	6.06e-06	724	63	9	36232890
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	MAP7D1 CALD1 MICALL2 SMC3 POLR2A DHX38 MAD1L1 SMC6 BUD13 EIF3A NEXN	6.54e-06	1155	63	11	20360068
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ABLIM1 MYH9 CALD1 MAP1A MYO6 PRRC2C ZMAT2 POLR2A DHX38 EIF3A	6.55e-06	934	63	10	33916271
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	ABLIM1 RBM25 CALD1 NF2 PRRC2C POLR2A AFDN TNIP1	6.62e-06	549	63	8	38280479
Pubmed	Defining the membrane proteome of NK cells.	MYH9 MIA3 NOP14 NF2 MYO6 PRRC2C DHX38 NUCB1 EIF3A CCDC77 NMD3	7.26e-06	1168	63	11	19946888
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	RBM25 CALD1 PRRC2C ZMAT2 POLR2A SMC6 BUD13 AFDN DGCR8 YTHDF3	7.88e-06	954	63	10	36373674
Pubmed	The anti-apoptotic activity associated with phosphatidylinositol transfer protein alpha activates the MAPK and Akt/PKB pathway.	PITPNA PITPNB	9.68e-06	3	63	2	18501717
Pubmed	YTHDF3 Facilitates eIF2AK2 and eIF3A Recruitment on mRNAs to Regulate Translational Processes in Oxaliplatin-Resistant Colorectal Cancer.	EIF3A YTHDF3	9.68e-06	3	63	2	35708211
Pubmed	Phosphatidylinositol transfer proteins regulate megakaryocyte TGF-β1 secretion and hematopoiesis in mice.	PITPNA PITPNB	9.68e-06	3	63	2	30042096
Pubmed	Muscle autoantigens in thyroid associated ophthalmopathy: the limits of molecular genetics.	RBM25 NEXN	9.68e-06	3	63	2	8227983
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	RTF1 PPP4R3B MYH9 CALD1 UBE4B POLR2A DHX38 MAD1L1 NUCB1 EIF3A ANKRD40 ELAC2	1.01e-05	1455	63	12	22863883
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	RTF1 MYH9 RBM25 NOP14 SMC3 POLR2A DHX38 EIF3A DGCR8 NMD3	1.08e-05	989	63	10	36424410
Pubmed	NDP52 interacts with mitochondrial RNA poly(A) polymerase to promote mitophagy.	MYH9 NEXN MYO5C	1.27e-05	25	63	3	30309841
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	MYH9 RBM25 NOP14 PRRC2C POLR2A DHX38 EIF3A ELAC2 YTHDF3	1.44e-05	807	63	9	22681889
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	ABLIM1 MYH9 MAP7D1 RBM25 NOP14 MYO6 SMC3 PRRC2C DHX38 BUD13 EIF3A	1.44e-05	1257	63	11	36526897
Pubmed	WWP2 ubiquitylates RNA polymerase II for DNA-PK-dependent transcription arrest and repair at DNA breaks.	MAP7D1 NF2 PRRC2C POLR2A EIF3A DGCR8 YTHDF3 NMD3	1.50e-05	615	63	8	31048545
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	ABLIM1 MYH9 CALD1 MAP1A MYO6 DHX38 YTHDF3	1.57e-05	444	63	7	34795231
Pubmed	Prediction of the coding sequences of unidentified human genes. VI. The coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by analysis of cDNA clones from cell line KG-1 and brain.	RTF1 MIA3 DHX38 MFN2	1.61e-05	83	63	4	9039502
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	ABLIM1 MIA3 CALD1 NF2 SMC3 AFDN CCDC77	1.62e-05	446	63	7	24255178
Pubmed	Phosphoproteomics screen reveals akt isoform-specific signals linking RNA processing to lung cancer.	MYH9 POLR2A PKD2	1.80e-05	28	63	3	24462114
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	MYH9 MIA3 SMC3 PRRC2C NUCB1 SNAP23 MFN2 TNIP1 EIF3A ELAC2 YTHDF3	1.93e-05	1297	63	11	33545068
Pubmed	Cloning and characterization of a novel human phosphatidylinositol transfer protein, rdgBbeta.	PITPNA PITPNB	1.93e-05	4	63	2	10531358
Pubmed	Cloning and developmental expression of nonmuscle myosin IIA (Myh9) in the mammalian inner ear.	MYH9 MYO6	1.93e-05	4	63	2	15079858
Pubmed	Myo15 function is distinct from Myo6, Myo7a and pirouette genes in development of cochlear stereocilia.	MYO6 MYO7A	1.93e-05	4	63	2	12966030
Pubmed	Vertebrate unconventional myosins.	MYO6 MYO7A	1.93e-05	4	63	2	8690736
Pubmed	A central to peripheral progression of cell cycle exit and hair cell differentiation in the developing mouse cristae.	MYO6 MYO7A	1.93e-05	4	63	2	26826497
Pubmed	Phosphatidylinositol transfer protein, cytoplasmic 1 (PITPNC1) binds and transfers phosphatidic acid.	PITPNA PITPNB	1.93e-05	4	63	2	22822086
Pubmed	A role for myosin VI in postsynaptic structure and glutamate receptor endocytosis.	MYO6 MYO7A	1.93e-05	4	63	2	15657400
Pubmed	In-depth genetic and molecular characterization of diaphanous related formin 2 (DIAPH2) and its role in the inner ear.	MYO6 MYO7A	1.93e-05	4	63	2	36689403
Pubmed	Structure of a multifunctional protein. Mammalian phosphatidylinositol transfer protein complexed with phosphatidylcholine.	PITPNA PITPNB	1.93e-05	4	63	2	11104777
Pubmed	Migrating Platelets Are Mechano-scavengers that Collect and Bundle Bacteria.	MYH9 POLR2A	1.93e-05	4	63	2	29195076
Pubmed	Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.	RTF1 MYH9 RBM25 NOP14 SMC3 POLR2A DHX38 NMD3	2.31e-05	653	63	8	33742100
Pubmed	Interaction proteomics identify NEURL4 and the HECT E3 ligase HERC2 as novel modulators of centrosome architecture.	MAP7D1 POLR2A SNAP23	2.46e-05	31	63	3	22261722
Pubmed	PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.	MYH9 RBM25 UBE4B MYO6 SMC3 EIF3A NEXN	2.49e-05	477	63	7	31300519
Pubmed	A human MAP kinase interactome.	ABLIM1 MYH9 MAP1A MYO6 SMC3 MAP3K10 EIF3A	2.81e-05	486	63	7	20936779
Pubmed	Styxl2 regulates de novo sarcomere assembly by binding to non-muscle myosin IIs and promoting their degradation.	MYH9 STYXL2	3.22e-05	5	63	2	38829202
Pubmed	Tracing Sox10-expressing cells elucidates the dynamic development of the mouse inner ear.	MYO6 MYO7A	3.22e-05	5	63	2	23684581
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	RTF1 MAP7D1 MYO6 SMC3 MYO7A POLR2A WNK4	3.23e-05	497	63	7	36774506
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	MYH9 MYO6 PRRC2C RNF112 MYO5C	3.36e-05	202	63	5	33005030
Pubmed	α-catenin interaction with YAP/FoxM1/TEAD-induced CEP55 supports liver cancer cell migration.	ABLIM1 SNAP23 AFDN	3.56e-05	35	63	3	37381005
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	ABLIM1 MYH9 RBM25 CALD1 MYO6 SMC3 PRRC2C AFDN	4.09e-05	708	63	8	39231216
Pubmed	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	MYH9 MAP7D1 NF2 MYO6 MAD1L1 NUCB1 BMERB1 BUD13 PITPNB	4.19e-05	925	63	9	28986522
Pubmed	RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.	MYH9 MAP7D1 RBM25 NOP14 PRRC2C DGCR8 ELAC2 YTHDF3	4.30e-05	713	63	8	29802200
Pubmed	Human transcription factor protein interaction networks.	SUPT3H MAP7D1 RBM25 NOP14 MYO6 SMC3 PRRC2C TNIP1 EIF3A YTHDF3 MYO5C	4.68e-05	1429	63	11	35140242
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	MYH9 MYO6 SMC3 MYO7A POLR2A PITPNA	4.73e-05	358	63	6	32460013
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	ABLIM1 MYH9 MAP7D1 CALD1 MAP1A LZTS3 MYO6 MYO7A PRRC2C AFDN EIF3A	4.73e-05	1431	63	11	37142655
Pubmed	Genomics and hearing impairment.	MYO6 MYO7A	4.82e-05	6	63	2	9927480
Pubmed	Selection of viral capsids and promoters affects the efficacy of rescue of Tmprss3-deficient cochlea.	MYO7A POLR2A	4.82e-05	6	63	2	37663645
Pubmed	Gpr125 Marks Distinct Cochlear Cell Types and Is Dispensable for Cochlear Development and Hearing.	MYO7A POLR2A	4.82e-05	6	63	2	34395423
Pubmed	Two novel transcripts encoding two Ankyrin repeat containing proteins have preponderant expression during the mouse spermatogenesis.	POTEB2 POTEB	4.82e-05	6	63	2	17171436
Pubmed	NDP52 activates nuclear myosin VI to enhance RNA polymerase II transcription.	MYO6 POLR2A	4.82e-05	6	63	2	29187741
Pubmed	An ENU-induced mutation of miR-96 associated with progressive hearing loss in mice.	MYO6 MYO7A	4.82e-05	6	63	2	19363478
Pubmed	Fgf8P2A-3×GFP/+: A New Genetic Mouse Model for Specifically Labeling and Sorting Cochlear Inner Hair Cells.	MYO6 MYO7A	4.82e-05	6	63	2	37233921
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	MYH9 MAP7D1 NOP14 CALD1 PRRC2C ZMAT2 RAB22A NUCB1 EIF3A CCDC77 POLQ	5.07e-05	1442	63	11	35575683
Pubmed	Characterizing ZC3H18, a Multi-domain Protein at the Interface of RNA Production and Destruction Decisions.	MYH9 RBM25 NOP14 SMC3 PRRC2C ZMAT2 BUD13 EIF3A	5.12e-05	731	63	8	29298432
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	ABLIM1 MYH9 MAP7D1 MIA3 LZTS3 PRRC2C MAD1L1 MFN2 AFDN	5.71e-05	963	63	9	28671696
Pubmed	Tails of unconventional myosins.	MYO6 MYO7A	6.74e-05	7	63	2	11212352
Pubmed	Requirement for Brn-3c in maturation and survival, but not in fate determination of inner ear hair cells.	MYO6 MYO7A	6.74e-05	7	63	2	9735355
Pubmed	Role of myosin VIIa and Rab27a in the motility and localization of RPE melanosomes.	MYO6 MYO7A	6.74e-05	7	63	2	15572405
Pubmed	Fate-mapping analysis of cochlear cells expressing Atoh1 mRNA via a new Atoh13*HA-P2A-Cre knockin mouse strain.	MYO6 MYO7A	6.74e-05	7	63	2	35038200
Pubmed	Myosins: a diverse superfamily.	MYO6 MYO7A	6.74e-05	7	63	2	10722873
Pubmed	Transcription profiling of inner ears from Pou4f3(ddl/ddl) identifies Gfi1 as a target of the Pou4f3 deafness gene.	MYO6 MYO7A	6.74e-05	7	63	2	15254021
Pubmed	The parafibromin tumor suppressor protein is part of a human Paf1 complex.	RTF1 POLR2A	6.74e-05	7	63	2	15632063
Pubmed	Protein interactome reveals converging molecular pathways among autism disorders.	MYH9 LZTS3 MAD1L1 NUCB1 TNIP1 EIF3A ANKRD40	6.86e-05	560	63	7	21653829
Pubmed	The Catalytically Inactive Mutation of the Ubiquitin-Conjugating Enzyme CDC34 Affects its Stability and Cell Proliferation.	SMC3 POLR2A MFN2 ELAC2 NMD3	7.18e-05	237	63	5	29564676
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	ABLIM1 MYH9 CALD1 NF2 MYO6 SNAP23 AFDN	7.25e-05	565	63	7	25468996
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	RTF1 SUPT3H MYH9 MYO6 SMC3 MYO7A SESN3 DAAM2 CCDC77 ELAC2	7.43e-05	1242	63	10	30973865
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ABLIM1 RBM25 UBE4B POLR2A MAD1L1 BUD13 AFDN KAT6B	7.63e-05	774	63	8	15302935
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	ABLIM1 MYH9 RBM25 NF2 MYO6 SMC3 POLR2A BUD13 ELAC2 YTHDF3	7.69e-05	1247	63	10	27684187
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	SUPT3H MYH9 MAP7D1 NF2 MYO6 SMC3 DHX38 EIF3A NMD3	7.91e-05	1005	63	9	19615732
Pubmed	The zinc finger transcription factor Gfi1, implicated in lymphomagenesis, is required for inner ear hair cell differentiation and survival.	MYO6 MYO7A	8.98e-05	8	63	2	12441305
Pubmed	Expression of LHX3 and SOX2 during mouse inner ear development.	MYO6 MYO7A	8.98e-05	8	63	2	17604700
Interaction	DBN1 interactions	ABLIM1 MYH9 CALD1 NF2 MYO6 SMC3 AFDN TNIP1 NEXN MYO5C	6.21e-07	417	63	10	int:DBN1
Interaction	LGR4 interactions	MYH9 RBM25 PRRC2C POLR2A DAAM2 AFDN EIF3A NEXN	1.53e-06	262	63	8	int:LGR4
Interaction	KBTBD4 interactions	MYH9 MIA3 MYO6 SMC3 POLR2A AFDN EIF3A ANKRD40	6.12e-06	316	63	8	int:KBTBD4
Interaction	WWTR1 interactions	ABLIM1 RBM25 CALD1 NF2 PRRC2C POLR2A PKD2 AFDN TNIP1	6.19e-06	422	63	9	int:WWTR1
Interaction	CAPZA2 interactions	ABLIM1 MYH9 CALD1 UBE4B MYO6 AFDN TNIP1 NEXN MYO5C	7.20e-06	430	63	9	int:CAPZA2
Interaction	NEXN interactions	MYH9 CALD1 TNIP1 NEXN MYO5C	9.60e-06	91	63	5	int:NEXN
Interaction	MYO19 interactions	ABLIM1 MYH9 CALD1 MYO6 MFN2 NEXN MYO5C	1.34e-05	252	63	7	int:MYO19
Interaction	MYO5C interactions	MYH9 CALD1 MYO6 TNIP1 NEXN MYO5C	1.41e-05	168	63	6	int:MYO5C
Interaction	MEN1 interactions	MYH9 RBM25 NOP14 UBE4B SMC3 POLR2A DHX38 MAD1L1 SMC6 AFDN EIF3A KAT6B YTHDF3	1.44e-05	1029	63	13	int:MEN1
Interaction	INVS interactions	MYH9 CALD1 MAP1A NUCB1 CEP164	1.45e-05	99	63	5	int:INVS
Interaction	CALD1 interactions	MYH9 CALD1 PRRC2C TNIP1 EIF3A NEXN MYO5C	1.85e-05	265	63	7	int:CALD1
Interaction	H3C1 interactions	MYH9 MAP7D1 MICALL2 MYO6 SMC3 PRRC2C ZMAT2 POLR2A DHX38 SMC6 TNIP1 KAT6B	1.93e-05	901	63	12	int:H3C1
Interaction	CLTB interactions	MYH9 MIA3 MYO6 SMC3 TNIP1 MYO5C	2.43e-05	185	63	6	int:CLTB
Interaction	RDX interactions	ABLIM1 CALD1 NF2 MYO7A SNAP23 TNIP1 NEXN	2.89e-05	284	63	7	int:RDX
Interaction	SIPA1L3 interactions	MYH9 CALD1 LZTS3 MYO6 AFDN	3.39e-05	118	63	5	int:SIPA1L3
Interaction	ARL14 interactions	NF2 MYO6 SNAP23 AFDN DGCR8	3.53e-05	119	63	5	int:ARL14
Interaction	RALBP1 interactions	ABLIM1 RBM25 POLR2A GAS8 TNIP1 CEP164	3.56e-05	198	63	6	int:RALBP1
Interaction	MYO18A interactions	ABLIM1 MYH9 CALD1 MYO6 TNIP1 NEXN MYO5C	4.36e-05	303	63	7	int:MYO18A
Interaction	FXR1 interactions	MYH9 MIA3 PRRC2C ZMAT2 MAD1L1 AFDN TNIP1 EIF3A ANKRD40 YTHDF3	4.49e-05	679	63	10	int:FXR1
Interaction	PPP1R9A interactions	CALD1 MYO6 AFDN TNIP1 NEXN	5.00e-05	128	63	5	int:PPP1R9A
Interaction	SMC5 interactions	MYH9 RBM25 CALD1 SMC3 PRRC2C ZMAT2 POLR2A SMC6 BUD13 AFDN DGCR8 YTHDF3	5.34e-05	1000	63	12	int:SMC5
Interaction	KCNA3 interactions	ABLIM1 MYH9 RBM25 CALD1 NF2 MYO6 SMC3 PRRC2C AFDN POLQ MYO5C	7.25e-05	871	63	11	int:KCNA3
Interaction	KLF8 interactions	MAP7D1 NOP14 SMC3 PRRC2C EIF3A DGCR8 YTHDF3	7.32e-05	329	63	7	int:KLF8
Interaction	CTTN interactions	MYH9 RBM25 CALD1 MYO6 TNIP1 NEXN YTHDF3 MYO5C	7.67e-05	450	63	8	int:CTTN
Interaction	SPECC1 interactions	MYH9 CALD1 AFDN TNIP1 MYO5C	8.47e-05	143	63	5	int:SPECC1
Interaction	CEP89 interactions	ABLIM1 MYH9 AFDN CCDC77 CEP164	9.65e-05	147	63	5	int:CEP89
Interaction	PPP1CB interactions	ABLIM1 MYH9 CALD1 MICALL2 MYO6 TNIP1 NEXN MYO5C	1.02e-04	469	63	8	int:PPP1CB
Interaction	YAP1 interactions	RTF1 ABLIM1 MYH9 RBM25 CALD1 NF2 MYO6 PRRC2C POLR2A AFDN EIF3A DGCR8	1.27e-04	1095	63	12	int:YAP1
Interaction	TMOD1 interactions	ABLIM1 MYH9 CALD1 NEXN MYO5C	1.48e-04	161	63	5	int:TMOD1
Interaction	MOV10 interactions	RBM25 NOP14 NF2 MYO6 PRRC2C POLR2A DHX38 TNIP1 PITPNB DGCR8 KAT6B CEP164 YTHDF3	1.56e-04	1297	63	13	int:MOV10
Interaction	AATF interactions	NOP14 SMC3 PRRC2C TNIP1 EIF3A DGCR8 CEP164	1.68e-04	376	63	7	int:AATF
Interaction	FEZ1 interactions	PPP4R3B UBE4B SMC3 PDCD7	1.81e-04	90	63	4	int:FEZ1
Interaction	PSPC1 interactions	MAP7D1 RBM25 NF2 PRRC2C POLR2A EIF3A YTHDF3 NMD3	1.94e-04	515	63	8	int:PSPC1
Interaction	GNL2 interactions	NOP14 MAP1A MYO6 DHX38 AFDN TNIP1 DGCR8	1.97e-04	386	63	7	int:GNL2
Interaction	CEP135 interactions	MIA3 LZTS3 ZMAT2 TNIP1 CCDC77 CEP164	2.04e-04	272	63	6	int:CEP135
Interaction	MYO1B interactions	MYH9 RBM25 CALD1 TNIP1 NEXN MYO5C	2.08e-04	273	63	6	int:MYO1B
Interaction	SLC25A18 interactions	TNIP1 ANKRD40 CEP164	2.65e-04	40	63	3	int:SLC25A18
Interaction	IFIT1B interactions	MAP1A DHX38	2.66e-04	8	63	2	int:IFIT1B
Interaction	ACTC1 interactions	RTF1 MYH9 RBM25 CALD1 MYO6 ZMAT2 TNIP1 NEXN MYO5C	2.90e-04	694	63	9	int:ACTC1
Interaction	SNIP1 interactions	RTF1 RBM25 NOP14 POLR2A BUD13 TNIP1 KAT6B	3.15e-04	417	63	7	int:SNIP1
Interaction	FLII interactions	MYH9 RBM25 CALD1 TNIP1 DGCR8 MYO5C	3.33e-04	298	63	6	int:FLII
Interaction	SYNPO interactions	ABLIM1 MYH9 MYO6 NEXN MYO5C	3.35e-04	192	63	5	int:SYNPO
Interaction	TNIP1 interactions	ABLIM1 MYH9 RBM25 CALD1 NF2 MYO6 SMC3 ZMAT2 TNIP1 EIF3A NEXN MYO5C	3.38e-04	1217	63	12	int:TNIP1
Interaction	KLF16 interactions	MAP7D1 NOP14 SMC3 PRRC2C TNIP1 EIF3A YTHDF3	3.53e-04	425	63	7	int:KLF16
Interaction	ZC3H18 interactions	RTF1 MYH9 RBM25 NOP14 SMC3 PRRC2C ZMAT2 BUD13 TRPM8 EIF3A	3.64e-04	877	63	10	int:ZC3H18
Interaction	FLNB interactions	MYH9 CALD1 PRRC2C MAD1L1 TNIP1 NMD3	3.70e-04	304	63	6	int:FLNB
Interaction	RIT1 interactions	SUPT3H RBM25 NF2 DHX38 SMC6 SNAP23 MFN2 AFDN EIF3A PDCD7 ELAC2 NMD3	3.72e-04	1230	63	12	int:RIT1
Interaction	DISC1 interactions	CALD1 MAP1A SMC3 DHX38 GAS8 NEXN CEP164	3.74e-04	429	63	7	int:DISC1
Interaction	LIMA1 interactions	ABLIM1 MYH9 CALD1 AFDN TNIP1 NEXN MYO5C	3.74e-04	429	63	7	int:LIMA1
Interaction	FXR2 interactions	MIA3 PRRC2C ZMAT2 SNAP23 TNIP1 NEXN YTHDF3	3.79e-04	430	63	7	int:FXR2
Interaction	PPIA interactions	RTF1 ABLIM1 MYH9 MAP1A NF2 POLR2A TNIP1 NEXN ELAC2 YTHDF3	4.02e-04	888	63	10	int:PPIA
Interaction	CDC14A interactions	MAP7D1 POLR2A EIF3A CCDC77	4.04e-04	111	63	4	int:CDC14A
Interaction	NDC80 interactions	MIA3 MAD1L1 TNIP1 CCDC77 CEP164 MYO5C	4.25e-04	312	63	6	int:NDC80
Interaction	ATXN3 interactions	MYH9 RBM25 UBE4B POLR2A SNAP23 MFN2 EIF3A	4.29e-04	439	63	7	int:ATXN3
Interaction	CDKL5 interactions	LZTS3 PRRC2C DHX38 AFDN	4.33e-04	113	63	4	int:CDKL5
Interaction	SUPT16H interactions	RTF1 RBM25 NF2 POLR2A DHX38 TNIP1 CEP164	4.47e-04	442	63	7	int:SUPT16H
Interaction	LRRC31 interactions	MYH9 MYO6 PRRC2C RNF112 MYO5C	4.52e-04	205	63	5	int:LRRC31
Interaction	CIT interactions	ABLIM1 MYH9 RBM25 NOP14 NF2 MYO6 SMC3 PRRC2C POLR2A DHX38 EIF3A PDCD7 NEXN	4.62e-04	1450	63	13	int:CIT
Interaction	CNOT3 interactions	RTF1 MAP1A PRRC2C MAP3K10 YTHDF3	4.72e-04	207	63	5	int:CNOT3
Interaction	TPRN interactions	MYH9 TNIP1 MYO5C	4.84e-04	49	63	3	int:TPRN
Interaction	CAPRIN1 interactions	MYH9 RBM25 NF2 PRRC2C TNIP1 EIF3A YTHDF3	5.04e-04	451	63	7	int:CAPRIN1
Interaction	ACTR2 interactions	MYH9 CALD1 MYO6 SMC3 TNIP1 MYO5C	5.10e-04	323	63	6	int:ACTR2
Interaction	ALS2CL interactions	NF2 RAB22A	5.19e-04	11	63	2	int:ALS2CL
Interaction	TDRD3 interactions	MIA3 PRRC2C POLR2A CCDC77 YTHDF3	5.26e-04	212	63	5	int:TDRD3
Interaction	GAGE5 interactions	MYH9 RBM25 MYO5C	5.77e-04	52	63	3	int:GAGE5
Interaction	PML interactions	ABLIM1 MYH9 CALD1 MAP1A MYO6 DHX38 MAD1L1 SMC6 EIF3A YTHDF3	5.91e-04	933	63	10	int:PML
Interaction	MAPT interactions	ABLIM1 MAP7D1 MAP1A NF2 MYO6 SMC3 DHX38 RAB22A AFDN EIF3A DGCR8	6.33e-04	1119	63	11	int:MAPT
Interaction	MAPRE2 interactions	GOLGA6L2 MAP1A SMC3 DGCR8	6.52e-04	126	63	4	int:MAPRE2
Interaction	H2AJ interactions	RTF1 RBM25 BUD13 TNIP1	6.72e-04	127	63	4	int:H2AJ
Interaction	TAX1BP1 interactions	MIA3 MYO6 PRRC2C TNIP1 ELAC2 YTHDF3	6.88e-04	342	63	6	int:TAX1BP1
Interaction	CRYL1 interactions	PKD2 CEP164 MYO5C	7.17e-04	56	63	3	int:CRYL1
Interaction	DDX23 interactions	RTF1 RBM25 NOP14 DHX38 BUD13 TNIP1 CEP164	7.28e-04	480	63	7	int:DDX23
Interaction	EIF3J interactions	PPP4R3B NF2 EIF3A PDCD7	7.34e-04	130	63	4	int:EIF3J
Interaction	TCEA1 interactions	RTF1 RBM25 ZMAT2 POLR2A	7.55e-04	131	63	4	int:TCEA1
Interaction	CALCOCO2 interactions	ABLIM1 MYH9 MYO6 POLR2A TNIP1 NEXN MYO5C	7.83e-04	486	63	7	int:CALCOCO2
Interaction	POLR1G interactions	RTF1 NOP14 ZMAT2 POLR2A DHX38 BUD13 TNIP1	8.12e-04	489	63	7	int:POLR1G
Interaction	NAA40 interactions	ABLIM1 MYH9 CALD1 MAP1A MYO6 PRRC2C ZMAT2 POLR2A DHX38 EIF3A	8.51e-04	978	63	10	int:NAA40
Interaction	ISG15 interactions	MYH9 RBM25 CALD1 MYO6 PRRC2C YTHDF3 MYO5C	8.62e-04	494	63	7	int:ISG15
Interaction	MYH11 interactions	MYH9 SMC3 TNIP1 EIF3A	8.68e-04	136	63	4	int:MYH11
Interaction	HECTD1 interactions	RBM25 NOP14 NF2 SMC3 PRRC2C SMC6 BUD13 DGCR8 PDCD7 MYO5C	8.91e-04	984	63	10	int:HECTD1
Interaction	SNRNP70 interactions	MYH9 MAP7D1 RBM25 NOP14 MYO6 PRRC2C POLR2A DGCR8 ELAC2 YTHDF3	8.91e-04	984	63	10	int:SNRNP70
Interaction	FLNA interactions	ABLIM1 MYH9 CALD1 MYO6 TNIP1 NEXN MYO5C NMD3	8.91e-04	648	63	8	int:FLNA
Interaction	TRIM56 interactions	MYH9 PRRC2C DGCR8 YTHDF3	8.92e-04	137	63	4	int:TRIM56
Interaction	LURAP1 interactions	NF2 TNIP1 CCDC77 MYO5C	8.92e-04	137	63	4	int:LURAP1
Interaction	CDR2 interactions	GOLGA6L2 MICALL2 ZMAT2 GAS8	8.92e-04	137	63	4	int:CDR2
Interaction	PNKP interactions	NF2 POLR2A GAS8 TNIP1	8.92e-04	137	63	4	int:PNKP
Interaction	RNGTT interactions	RTF1 PPP4R3B NOP14 POLR2A	8.92e-04	137	63	4	int:RNGTT
Cytoband	10q25	ABLIM1 SMC3	1.01e-04	11	63	2	10q25
Cytoband	Ensembl 112 genes in cytogenetic band chr1q24	PRRC2C STYXL2 CCDC181	7.61e-04	129	63	3	chr1q24
Cytoband	Ensembl 112 genes in cytogenetic band chr15q15	RTF1 MAP1A SNAP23	1.11e-03	147	63	3	chr15q15
Cytoband	15q11.2	GOLGA6L2 POTEB2 POTEB	1.74e-03	172	63	3	15q11.2
Cytoband	Ensembl 112 genes in cytogenetic band chr15q11	GOLGA6L2 POTEB2 POTEB	3.36e-03	217	63	3	chr15q11
Cytoband	Ensembl 112 genes in cytogenetic band chr22q12	MYH9 NF2 PITPNB	4.19e-03	235	63	3	chr22q12
Cytoband	11q23.3	BUD13 CEP164	5.20e-03	78	63	2	11q23.3
GeneFamily	Phosphatidylinositol transfer proteins	PITPNA PITPNB	6.76e-05	6	39	2	1151
GeneFamily	Structural maintenance of chromosomes proteins\|Cohesin complex	SMC3 SMC6	9.46e-05	7	39	2	761
GeneFamily	Ankyrin repeat domain containing\|POTE ankyrin domain containing	POTEB2 POTEB	3.48e-04	13	39	2	685
GeneFamily	Myosin heavy chains	MYH9 MYH16	4.68e-04	15	39	2	1098
GeneFamily	Transient receptor potential cation channels	PKD2 TRPM8	1.65e-03	28	39	2	249
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	NF2 MYO7A	1.77e-03	29	39	2	396
GeneFamily	Actins\|Deafness associated genes	MYH9 MYO6 MYO7A	1.84e-03	113	39	3	1152
GeneFamily	Ankyrin repeat domain containing\|FERM domain containing	NF2 MYO7A	5.20e-03	50	39	2	1293
GeneFamily	LIM domain containing	ABLIM1 MICALL2	7.18e-03	59	39	2	1218
GeneFamily	Ankyrin repeat domain containing	POTEB2 ANKRD40 POTEB	1.52e-02	242	39	3	403
Coexpression	BRUINS_UVC_RESPONSE_EARLY_LATE	CALD1 MAP1A SMC3 SMC6 GAS8 SNAP23 EIF3A	1.07e-05	316	63	7	M2248
Coexpression	BRUINS_UVC_RESPONSE_EARLY_LATE	CALD1 MAP1A SMC3 SMC6 GAS8 SNAP23 EIF3A	1.17e-05	320	63	7	MM1063
Coexpression	LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2	ABLIM1 RBM25 CALD1 MYO6 PRRC2C AFDN	1.53e-05	221	63	6	M39222
Coexpression	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN	RTF1 RBM25 MIA3 RAB22A SMC6 PITPNB DGCR8 YTHDF3	3.33e-05	519	63	8	M3395
Coexpression	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN	RTF1 RBM25 MIA3 RAB22A SMC6 PITPNB DGCR8 YTHDF3	4.59e-05	543	63	8	MM997
Coexpression	MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS	RBM25 SMC3 EIF3A KAT6B	6.63e-05	90	63	4	M39250
Coexpression	CHESLER_BRAIN_QTL_TRANS	MYH9 PITPNB	8.48e-05	6	63	2	MM616
Coexpression	CHESLER_BRAIN_QTL_TRANS	MYH9 PITPNB	8.48e-05	6	63	2	M7189
Coexpression	GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP	RTF1 DHX38 PKD2 DGCR8 CCDC77	1.07e-04	195	63	5	M9218
Coexpression	GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_UP	MIA3 TNIP1 ANKRD40 ELAC2 CEP164	1.12e-04	197	63	5	M5363
Coexpression	GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_UP	SUPT3H SMC3 BMERB1 POLQ ELAC2	1.21e-04	200	63	5	M4626
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1	RBM25 NOP14 MYO6 SMC3 PRRC2C ZMAT2 DHX38 TNIP1 EIF3A	9.52e-06	469	63	9	Facebase_RNAseq_e8.5_Floor Plate_2500_K1
CoexpressionAtlas	DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_1000	PPP4R3B RBM25 CALD1 MYO7A SESN3 SNAP23 EIF3A DGCR8 ANKRD40 CEP164	1.38e-04	819	63	10	gudmap_developingGonad_e12.5_testes_1000
CoexpressionAtlas	DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#1_top-relative-expression-ranked_1000	PPP4R3B CALD1 SESN3 SNAP23 EIF3A DGCR8 ANKRD40 CEP164	1.53e-04	524	63	8	gudmap_developingGonad_e12.5_testes_k1_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	RBM25 NOP14 SMC3 PRRC2C DHX38 SMC6 EIF3A POLQ	1.70e-04	532	63	8	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000	PPP4R3B RBM25 CALD1 PRRC2C SNAP23 PITPNB EIF3A DGCR8 ANKRD40 CEP164	1.75e-04	843	63	10	gudmap_developingGonad_e11.5_testes_1000
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	RTF1 RBM25 MYO6 PRRC2C POLR2A EIF3A NEXN CEP164	3.69e-10	197	63	8	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	(01)_IL1RL1+-(2)_GFP_FOXI1\|(01)_IL1RL1+ / shred by cell type by condition	RTF1 RBM25 CALD1 SMC3 PRRC2C SMC6 BMERB1	1.34e-08	199	63	7	a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCell	(00)_Basal-(2)_GFP_FOXI1\|(00)_Basal / shred by cell type by condition	RTF1 CALD1 MYO6 SMC3 PRRC2C BMERB1	3.82e-07	199	63	6	19674e1eaeb51e4196d847cb62aa437c852951d3
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	ABLIM1 MYH9 CALD1 MYO6 MYO5C	4.27e-06	170	63	5	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CALD1 RNF112 PKD2 DAAM2 NEXN	4.92e-06	175	63	5	1799a7be623dc3bf53ba580a7c47d2619969d708
ToppCell	Brain_organoid-organoid_Kanton_Nature\|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type.	RBM25 SMC3 PRRC2C AFDN PDCD7	6.45e-06	185	63	5	857c7ca8493e91ef1d0078ddafd6082020f9b169
ToppCell	droplet-Tongue-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RTF1 RBM25 SMC3 PRRC2C EIF3A	6.97e-06	188	63	5	d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ABLIM1 MYH9 CALD1 AFDN EIF3A	7.34e-06	190	63	5	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	ABLIM1 SLC8A1 MYH9 CALD1 NEXN	7.34e-06	190	63	5	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	Control-Stromal-SMC\|Stromal / Disease state, Lineage and Cell class	SLC8A1 MYH9 CALD1 DAAM2 NEXN	7.53e-06	191	63	5	2da83c493e60ad0278848957645277d76737a188
ToppCell	(05)_Secretory-(2)_GFP_FOXI1\|(05)_Secretory / shred by cell type by condition	RTF1 RBM25 MYO6 SMC3 PRRC2C	9.19e-06	199	63	5	d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098
ToppCell	(02)_MMP9/10+-(2)_GFP_FOXI1\|(02)_MMP9/10+ / shred by cell type by condition	RTF1 CALD1 SMC6 SESN3 NEXN	9.19e-06	199	63	5	18a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCell	(04)_Interm._basal>secr.-(2)_GFP_FOXI1\|(04)_Interm._basal>secr. / shred by cell type by condition	RTF1 RBM25 MYO6 SMC3 PRRC2C	9.19e-06	199	63	5	53ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SLC8A1 CALD1 MAP1A DAAM2 NEXN	9.41e-06	200	63	5	9169a9ec8e9ab95d90a64c5a19ac666a5cf82313
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SLC8A1 CALD1 PKD2 DAAM2 NEXN	9.41e-06	200	63	5	f599e4b051ac3dad11ad437e98dc8ea6754cca53
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SLC8A1 CALD1 MAP1A DAAM2 NEXN	9.41e-06	200	63	5	a3a1e35934d676c39f917652e50c502cb2f613c1
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-1m-Mesenchymal-Mesoderm\|1m / Sample Type, Dataset, Time_group, and Cell type.	NOP14 TMC7 MICALL2 DHX38 ANKRD40	9.41e-06	200	63	5	c0ad32e9dd7f481c2665587fd8bd9fffc2e725f9
ToppCell	RV-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	ABLIM1 SLC8A1 GOLGA6L2 NEXN	2.71e-05	122	63	4	1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3
ToppCell	normal-na-Lymphocytic_T-T4_em-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	PRRC2C AFDN EIF3A KAT6B	1.01e-04	171	63	4	61318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYH9 NOP14 CALD1 DAAM2	1.10e-04	175	63	4	12f5fd83c7710fc0c77406f765d9cbd133433b8b
ToppCell	AT1_cells-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	ABLIM1 AFDN NEXN MYO5C	1.15e-04	177	63	4	3128b8d04687acee1ac4190b2569d6328b98eaf3
ToppCell	Pericytes-Donor_05\|World / lung cells shred on cell class, cell subclass, sample id	CALD1 MAP1A BMERB1 NEXN	1.18e-04	178	63	4	a2448d868da2abe48c394c51264aad03e866dfec
ToppCell	droplet-Kidney-nan-18m-Epithelial-Stroma____kidney_mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CALD1 MAP1A DAAM2 NEXN	1.23e-04	180	63	4	b6f44fdedc33b7d93b0074e8e9c8cc32009d4c4d
ToppCell	Pericytes-Donor_01\|World / lung cells shred on cell class, cell subclass, sample id	CALD1 RNF112 BMERB1 NEXN	1.25e-04	181	63	4	ff445a8e56522e57e27405184d123cf905caf8cc
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CALD1 MAP1A RNF112 NEXN	1.25e-04	181	63	4	c62b0a2422377ffadaab63edd538e87a06fa5017
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CALD1 MAP1A RNF112 NEXN	1.25e-04	181	63	4	c6d2a13df3b74fade3b0c71e285b4c14c8e52413
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PPP4R3B ABLIM1 SESN3 AFDN	1.28e-04	182	63	4	c0f63cfc67d61c0877b7acb2946dfb35aae8a8f5
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PPP4R3B ABLIM1 SESN3 AFDN	1.28e-04	182	63	4	4cb182ef39be2044a6ad7266f332d4177591e550
ToppCell	Pericytes-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	CALD1 MAP1A RNF112 NEXN	1.31e-04	183	63	4	4617b18da8d699a44e4c47980197b1e7eb951470
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-Stroma____kidney_mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CALD1 MAP1A DAAM2 NEXN	1.31e-04	183	63	4	8de4b616a06be03e1cb6ae6a9ce6bf06485629d3
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	ABLIM1 SLC8A1 CALD1 NEXN	1.34e-04	184	63	4	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	Megakaryocytic-erythropoietic-Megakaryo-cells-Platelet\|World / Lineage, cell class and subclass	CALD1 MAP1A SNAP23 NEXN	1.39e-04	186	63	4	27807334e7241c8a9aeaf6403f0fd0b001fbc0d1
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLC8A1 CALD1 STYXL2 DAAM2	1.39e-04	186	63	4	4780af76237d7af2abbe2d8d5530cdf53e3ed0b7
ToppCell	Epithelial-alveolar_epithelial_cell_type_1\|World / Lineage, Cell type, age group and donor	ABLIM1 MYO6 AFDN MYO5C	1.39e-04	186	63	4	09d95daa3387a4814cffaa4b798cc2810c3759d0
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SLC8A1 RBM25 PRRC2C DAAM2	1.39e-04	186	63	4	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	droplet-Bladder-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RTF1 RBM25 NOP14 PRRC2C	1.42e-04	187	63	4	663991a8afe652e92363b64bcbd68c14d0307f0e
ToppCell	droplet-Spleen-nan-3m-Lymphocytic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABLIM1 PRRC2C SMC6 SESN3	1.42e-04	187	63	4	91c8e93bde0d1d1a4e324b0acf2afda00f4fb3bf
ToppCell	droplet-Spleen-nan-3m-Lymphocytic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABLIM1 PRRC2C SMC6 SESN3	1.42e-04	187	63	4	382db691eb0b3e089e816bed3d6699cc2d4e1bda
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	SLC8A1 MYH9 CALD1 NEXN	1.45e-04	188	63	4	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	droplet-Kidney-nan-18m-Epithelial-kidney_mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CALD1 MAP1A DAAM2 NEXN	1.45e-04	188	63	4	d1a4cd4db95d8d32b79156290f7867f32824cc87
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ABLIM1 MYO6 AFDN MYO5C	1.45e-04	188	63	4	eea652bab161f19148a883e7e3fe2523b36b3cea
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TMC7 MYO6 AFDN MYO5C	1.45e-04	188	63	4	43a3a59f92ad93509d4166bd025aed0b1b39a008
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLC8A1 CALD1 DAAM2 NEXN	1.45e-04	188	63	4	b2d68a32314e9b099ed74d974079ad96359d1ae3
ToppCell	remission-Platelet\|World / disease stage, cell group and cell class	CALD1 MAP1A SNAP23 NEXN	1.45e-04	188	63	4	fa69f20ef6b8ce620ba342f0984d40ddf259bc3f
ToppCell	PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_3\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CALD1 MAP1A SNAP23 NEXN	1.48e-04	189	63	4	d357fa946b9d6af46c15402f68758fb9c747bcaf
ToppCell	PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_3\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CALD1 MAP1A SNAP23 NEXN	1.48e-04	189	63	4	8b4a9434d7b7ca8cf74712227407ed7c96ce02f8
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLC8A1 CALD1 DAAM2 NEXN	1.48e-04	189	63	4	2cfb4d12f75678d1619f4743838a0e954bd57761
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	ABLIM1 SLC8A1 MYH9 NEXN	1.48e-04	189	63	4	0a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D231\|Adult / Lineage, Cell type, age group and donor	ABLIM1 TMC7 AFDN MYO5C	1.48e-04	189	63	4	5a04cb25f8f0447b2cecdb6c3695029281aca26d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLC8A1 CALD1 DAAM2 NEXN	1.48e-04	189	63	4	127ad2ba3e794df8cce2eee3e4171bccb5aad51b
ToppCell	droplet-Kidney-nan-21m-Epithelial-kidney_mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CALD1 MAP1A DAAM2 NEXN	1.51e-04	190	63	4	1803b1e7c36285f9eaabc3c6e9a9752c5908db3d
ToppCell	pdx-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	MAD1L1 DGCR8 CCDC77 POLQ	1.51e-04	190	63	4	d06ee5f89f1cec8db6897fe3b2a890a07cd3697b
ToppCell	Megakaryocytic-erythropoietic-Megakaryo-cells\|World / Lineage, cell class and subclass	CALD1 MAP1A SNAP23 NEXN	1.51e-04	190	63	4	72b61a12ccea506272ce9cef9051aa2612e6ce57
ToppCell	droplet-Kidney-nan-21m-Epithelial-Stroma____kidney_mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CALD1 MAP1A DAAM2 NEXN	1.51e-04	190	63	4	e04f47705851563515b6a66a2634cf7a574f7bda
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-smooth_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC8A1 CALD1 DAAM2 NEXN	1.54e-04	191	63	4	8e8beb8e8a3b33cac83d3f7ce915a71e3654fdab
ToppCell	LA-03._Atrial_Cardiomyocyte\|LA / Chamber and Cluster_Paper	ABLIM1 SLC8A1 CALD1 NEXN	1.54e-04	191	63	4	5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9
ToppCell	PBMC-Severe-Hematopoietic-Platelet-Platelet\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CALD1 MAP1A SNAP23 NEXN	1.57e-04	192	63	4	f48202c271c9233c78de255a2fa131b219f688d7
ToppCell	PBMC-Severe-Hematopoietic-Platelet\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CALD1 MAP1A SNAP23 NEXN	1.57e-04	192	63	4	35ae787e90e7e5e333978125e19de1590316c769
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SLC8A1 CALD1 DAAM2 NEXN	1.57e-04	192	63	4	24e2f15f5767a97eb3b389922bcfd7b13805e1ce
ToppCell	droplet-Kidney-nan-3m-Epithelial-kidney_mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CALD1 MAP1A DAAM2 NEXN	1.57e-04	192	63	4	3617d2bc7e33d981f3ec349e9962d8d4bd822fbd
ToppCell	COVID-19_Severe-Hematopoietic_Mega-Platelet\|COVID-19_Severe / Disease group, lineage and cell class	CALD1 MAP1A SNAP23 NEXN	1.57e-04	192	63	4	6ebdb70cc0292e41b348d38d89f77e9a3b029bd8
ToppCell	COVID-19_Severe-Hematopoietic_Mega\|COVID-19_Severe / Disease group, lineage and cell class	CALD1 MAP1A SNAP23 NEXN	1.57e-04	192	63	4	2764c3c68982077a448ff5da58344e0f6cec0a52
ToppCell	PBMC-Severe-Hematopoietic-Platelet-Platelet\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CALD1 MAP1A SNAP23 NEXN	1.57e-04	192	63	4	3276bd4f1023a020ebb26ec33424b6e9897d31c9
ToppCell	PBMC-Severe-Hematopoietic-Platelet\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	CALD1 MAP1A SNAP23 NEXN	1.57e-04	192	63	4	9ae14279e9b91e04ea2c5bbbeadb111a1b966bd1
ToppCell	severe_COVID-19\|World / disease group, cell group and cell class (v2)	CALD1 MAP1A DAAM2 NEXN	1.60e-04	193	63	4	9012cadd138be775fb167a5bc895e512619f8a95
ToppCell	PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_5\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CALD1 MAP1A SNAP23 NEXN	1.60e-04	193	63	4	a2fb7482e79d6ce5b6b1d9d0c0811d1c58b4d85d
ToppCell	PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_5\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CALD1 MAP1A SNAP23 NEXN	1.60e-04	193	63	4	1d724ccb745cfc624119dd6003d53b84b17c94b0
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ABLIM1 LZTS3 PRRC2C SESN3	1.60e-04	193	63	4	4e78ddc96d8e403a21c4a303b1f26512d2ac91e8
ToppCell	RA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	SLC8A1 MYH9 CALD1 NEXN	1.64e-04	194	63	4	89812fb164065041357bb37a3c2d87028ec3de4e
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CALD1 PKD2 DAAM2 NEXN	1.64e-04	194	63	4	8fae8061b350336299aa81f378e07deadbd55123
ToppCell	10x5'-blood-Hematopoietic_Erythro-Mega-Megakaryocyte_early\|blood / Manually curated celltypes from each tissue	CALD1 MAP1A SNAP23 NEXN	1.64e-04	194	63	4	63dea7d630962761a70aa88e720ee35c22cbc81a
ToppCell	10x5'-blood-Hematopoietic_Erythro-Mega\|blood / Manually curated celltypes from each tissue	CALD1 MAP1A SNAP23 NEXN	1.64e-04	194	63	4	d0e7d35b5086834929c4bd39d4c6719b2d5fc71e
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	ABLIM1 SLC8A1 CALD1 NEXN	1.64e-04	194	63	4	c3535f7cc0076653c72db582047cff053c322397
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CALD1 PKD2 DAAM2 NEXN	1.64e-04	194	63	4	4d7d24390fdb379f943ddcc70a63f23955e10163
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC8A1 MIA3 MYO6 PRRC2C	1.67e-04	195	63	4	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ABLIM1 PRRC2C SMC6 SESN3	1.67e-04	195	63	4	ed5f772c82d4dfd1c8735224446ec9feae3fb8c2
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC8A1 MIA3 MYO6 PRRC2C	1.67e-04	195	63	4	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NOP14 CALD1 PRRC2C NEXN	1.67e-04	195	63	4	5c86fddd6d0530beecf45ea5ba6b823123847696
ToppCell	severe_COVID-19-Platelet\|severe_COVID-19 / disease group, cell group and cell class (v2)	CALD1 MAP1A SNAP23 NEXN	1.70e-04	196	63	4	2b835fc3db81550555cbbcb3e823d9197ee35662
ToppCell	Megakaryocytic-erythropoietic-Megakaryo-cells\|Megakaryocytic-erythropoietic / Lineage, cell class and subclass	MYH9 CALD1 SNAP23 NEXN	1.70e-04	196	63	4	21ad9a63242e33038f9f531dd4074a5a9304ed62
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SLC8A1 CALD1 PKD2 NEXN	1.74e-04	197	63	4	bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-IPC_like\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	CALD1 MYO6 AFDN KAT6B	1.77e-04	198	63	4	6d12ecaa9532c134d9c4562534dcb59a6420b4d3
ToppCell	COVID-19_Mild\|World / Disease condition and Cell class	MYH9 RBM25 PRRC2C NEXN	1.77e-04	198	63	4	61ceb2245b6cb58e308b999a61d218c89dbc615e
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-IPC_like-IPs_and_early_cortical_neurons\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	CALD1 MYO6 AFDN KAT6B	1.77e-04	198	63	4	7943e4f67c3d6efb5c8b00aa0ff3cfe7be10c48d
ToppCell	ASK452-Epithelial-Type_1\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	ABLIM1 MAP7D1 SNAP23 NEXN	1.80e-04	199	63	4	48cafe44951908d03f3c6f3e185e9cbb86fb5b3b
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	RTF1 SMC3 PRRC2C SMC6	1.80e-04	199	63	4	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	megakaryocytic-CD34+_Megakaryoblast\|megakaryocytic / Lineage and Cell class	RBM25 SMC3 PRRC2C EIF3A	1.80e-04	199	63	4	99a65887d3c8a2cde26693dd74404b101bba9d58
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SLC8A1 MYH9 CALD1 DAAM2	1.84e-04	200	63	4	786f1ae53e60b5ffbf4bfd393d10b802478148b3
ToppCell	COVID-19-COVID-19_Severe-Others-Platelet\|COVID-19_Severe / Disease, condition lineage and cell class	CALD1 MAP1A SNAP23 NEXN	1.84e-04	200	63	4	af373636f540544addd94f51ce94ea2cb1f3ecc9
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SLC8A1 CALD1 DAAM2 NEXN	1.84e-04	200	63	4	67dcbd86fbc79fd585d0793f979e4aac100326c9
ToppCell	COVID-19-COVID-19_Convalescent-Others-Platelet\|COVID-19_Convalescent / Disease, condition lineage and cell class	CALD1 MAP1A SNAP23 NEXN	1.84e-04	200	63	4	5547e7173293fce403706f69331ce3976da73a32
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_only / Treatment groups by lineage, cell group, cell type	CALD1 MAP1A DAAM2 NEXN	1.84e-04	200	63	4	a9ff3210127000b3dd9e97136163c98c2b0817d7
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SLC8A1 CALD1 PKD2 NEXN	1.84e-04	200	63	4	dcdaec3ca3a3024dc1b8788c417003f84c2bffdc
ToppCell	Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CALD1 MAP1A DAAM2 WNK4	1.84e-04	200	63	4	29054cf55e88e1ac81a562d8dd9af9b7c749321d
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Neuron\|2m / Sample Type, Dataset, Time_group, and Cell type.	CALD1 MYO6 AFDN KAT6B	1.84e-04	200	63	4	a581f1704a87b0390e1e2ff85053367d85247755
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABLIM1 MYO6 PITPNA MYO5C	1.84e-04	200	63	4	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_3\|Control_saline / Treatment groups by lineage, cell group, cell type	SLC8A1 CALD1 DAAM2 NEXN	1.84e-04	200	63	4	b0866b497aa71d06cef25f9a335fa584e95fa7e0
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|Control_saline / Treatment groups by lineage, cell group, cell type	CALD1 PKD2 DAAM2 NEXN	1.84e-04	200	63	4	a799fc7bb83ad0524362cb5010df949741fb7bf3
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABLIM1 MIA3 PITPNA MYO5C	1.84e-04	200	63	4	0eb9ad8c0373bcc62029ec21c590ed03aaacd039
ToppCell	Control_saline-Mesenchymal_myocytic\|Control_saline / Treatment groups by lineage, cell group, cell type	SLC8A1 CALD1 DAAM2 NEXN	1.84e-04	200	63	4	5ed4261157cd51109b314818133ac3a0d34ee5fa
Computational	Neighborhood of RAB10	PRRC2C RAB22A SESN3 PITPNB YTHDF3 NMD3	8.48e-05	176	45	6	GCM_RAB10
Drug	Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A	ABLIM1 RBM25 CALD1 MYO6 SMC3 PRRC2C KAT6B	5.43e-07	178	62	7	3998_DN
Drug	Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A	ABLIM1 RBM25 MYO6 SMC3 PRRC2C MFN2 KAT6B	7.84e-07	188	62	7	6735_DN
Drug	Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A	RBM25 CALD1 MYO6 SMC3 PRRC2C KAT6B	9.27e-06	179	62	6	4585_DN
Drug	formycin triphosphate	MYH9 MYO6 AFDN MYO5C	1.13e-05	51	62	4	CID000122274
Drug	ikarugamycin; Down 200; 2uM; MCF7; HT_HG-U133A_EA	PPP4R3B SUPT3H NF2 MFN2 KAT6B ANKRD40	1.42e-05	193	62	6	866_DN
Drug	1,1-dimethylbiguanide hydrochloride; Down 200; 10uM; MCF7; HG-U133A	RBM25 UBE4B PKD2 EIF3A DGCR8 ELAC2	1.55e-05	196	62	6	2_DN
Drug	Cefoxitin sodium salt [33564-30-6]; Up 200; 8.8uM; HL60; HT_HG-U133A	ABLIM1 CALD1 NF2 MYO6 AFDN CCDC181	1.55e-05	196	62	6	2735_UP
Drug	PNU-0251126 [267429-19-6]; Down 200; 1uM; PC3; HT_HG-U133A	PPP4R3B SUPT3H CALD1 MAP1A NF2 ANKRD40	1.60e-05	197	62	6	7390_DN
Drug	Mephenytoin [50-12-4]; Down 200; 18.4uM; MCF7; HT_HG-U133A	RTF1 MICALL2 NUCB1 SNAP23 MFN2 ANKRD40	1.60e-05	197	62	6	6275_DN
Drug	blebbistatin	MYH9 MYO6 MYO7A AFDN MYO5C	1.62e-05	116	62	5	CID003476986
Drug	B0683	MYH9 MYO6 PKD2 AFDN MYO5C	1.68e-05	117	62	5	CID006398969
Drug	chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HT_HG-U133A_EA	RTF1 ABLIM1 MYH9 NF2 NUCB1 PKD2	1.69e-05	199	62	6	1055_DN
Drug	purealin	MYH9 MYO6 AFDN MYO5C	1.89e-05	58	62	4	CID006419303
Drug	1,2-cyclopentanediol	NUCB1 MYO5C	4.36e-05	4	62	2	CID000095497
Drug	Argentine	MYH9 SMC3 TNIP1	9.90e-05	33	62	3	CID000442941
Drug	ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA	RBM25 MYO6 SMC3 PRRC2C KAT6B	1.21e-04	177	62	5	985_DN
Drug	geldanamycin; Up 200; 1uM; HL60; HT_HG-U133A	LZTS3 NUCB1 SNAP23 KAT6B MYO5C	1.28e-04	179	62	5	1169_UP
Drug	YM-11170	MYH9 MYO6 MYO7A	1.29e-04	36	62	3	CID000003325
Drug	S-(-)-Etomoxir	MYH9 MYO6 AFDN MYO5C	1.61e-04	100	62	4	CID000060765
Drug	Rolipram [61413-54-5]; Up 200; 14.6uM; HL60; HT_HG-U133A	LZTS3 POLR2A GAS8 DGCR8 MYO5C	1.65e-04	189	62	5	3072_UP
Drug	Leflunomide [75706-12-6]; Up 200; 14.8uM; HL60; HT_HG-U133A	ABLIM1 CALD1 NF2 MYO6 BMERB1	1.69e-04	190	62	5	2539_UP
Drug	Butamben [94-25-7]; Down 200; 20.6uM; PC3; HT_HG-U133A	SUPT3H TMC7 NF2 SNAP23 DGCR8	1.73e-04	191	62	5	5792_DN
Drug	Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A	ABLIM1 MYO6 SMC3 PRRC2C KAT6B	1.73e-04	191	62	5	4283_DN
Drug	Famprofazone [22881-35-2]; Down 200; 10.6uM; PC3; HT_HG-U133A	RTF1 NF2 MYO6 SNAP23 MFN2	1.77e-04	192	62	5	3753_DN
Drug	ICI 182,780; Down 200; 1uM; MCF7; HG-U133A	SLC8A1 UBE4B MYO6 PITPNA CEP164	1.77e-04	192	62	5	367_DN
Drug	2-propylpentanoic acid; Down 200; 1000uM; SKMEL5; HG-U133A	RBM25 RAB22A EIF3A KAT6B ANKRD40	1.82e-04	193	62	5	629_DN
Drug	Ozagrel hydrochloride [78712-43-3]; Up 200; 15.2uM; HL60; HT_HG-U133A	MYH9 RBM25 PRRC2C POLR2A AFDN	1.91e-04	195	62	5	2942_UP
Drug	trifluoperazine dihydrochloride; Up 200; 10uM; HL60; HT_HG-U133A	ABLIM1 LZTS3 NF2 DGCR8 CEP164	1.91e-04	195	62	5	6183_UP
Drug	haloperidol; Down 200; 10uM; HL60; HT_HG-U133A	MAP1A NF2 MYO6 MFN2 ANKRD40	1.91e-04	195	62	5	2663_DN
Drug	Chicago sky blue 6B [2610-05-1]; Down 200; 4uM; HL60; HT_HG-U133A	PPP4R3B NF2 MICALL2 MFN2 CEP164	1.91e-04	195	62	5	1330_DN
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	PPP4R3B SUPT3H RBM25 MFN2 KAT6B	1.95e-04	196	62	5	987_DN
Drug	Quipazine dimaleate salt [4774-24-7]; Up 200; 9uM; MCF7; HT_HG-U133A	CALD1 NF2 MYO7A AFDN CCDC181	1.95e-04	196	62	5	7240_UP
Drug	CP-863187 [668981-07-5]; Up 200; 10uM; PC3; HT_HG-U133A	MIA3 CALD1 UBE4B BMERB1 DGCR8	1.95e-04	196	62	5	7558_UP
Drug	Azapropazone [13539-59-8]; Up 200; 13.4uM; HL60; HT_HG-U133A	CALD1 NF2 GAS8 AFDN CCDC181	2.00e-04	197	62	5	3143_UP
Drug	Sulfadiazine [68-35-9]; Down 200; 16uM; PC3; HT_HG-U133A	PPP4R3B SUPT3H CALD1 LZTS3 NF2	2.00e-04	197	62	5	5098_DN
Drug	Diloxanide furoate [3736-81-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A	SUPT3H MAP1A MYO7A DGCR8 CEP164	2.00e-04	197	62	5	3399_UP
Drug	Ajmalicine hydrochloride [4373-34-6]; Down 200; 10.2uM; PC3; HT_HG-U133A	MAP7D1 MICALL2 UBE4B DHX38 SNAP23	2.00e-04	197	62	5	6360_DN
Drug	prazosin hydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A_EA	PPP4R3B SUPT3H NF2 SNAP23 KAT6B	2.00e-04	197	62	5	826_DN
Drug	Vigabatrin [60643-86-9]; Up 200; 31uM; PC3; HT_HG-U133A	CALD1 NF2 MYO7A GAS8 DGCR8	2.00e-04	197	62	5	6314_UP
Drug	2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A	PPP4R3B NF2 MICALL2 PKD2 SNAP23	2.00e-04	197	62	5	6974_DN
Drug	5155877; Down 200; 10uM; PC3; HT_HG-U133A	PPP4R3B CALD1 TMC7 NF2 MFN2	2.05e-04	198	62	5	6544_DN
Drug	Meclozine dihydrochloride [1104-22-9]; Up 200; 8.6uM; HL60; HT_HG-U133A	ABLIM1 TMC7 NF2 MYO6 GAS8	2.05e-04	198	62	5	2424_UP
Drug	rofecoxib; Down 200; 10uM; MCF7; HG-U133A	ABLIM1 RBM25 MYO6 SNAP23 ANKRD40	2.05e-04	198	62	5	166_DN
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A_EA	SUPT3H NF2 UBE4B POLR2A KAT6B	2.05e-04	198	62	5	1082_DN
Drug	phenformin hydrochloride; Down 200; 10uM; MCF7; HG-U133A	ABLIM1 LZTS3 NF2 UBE4B MYO7A	2.05e-04	198	62	5	21_DN
Drug	novobiocin sodium, USP; Down 200; 100uM; MCF7; HG-U133A	UBE4B MYO6 DHX38 KAT6B ELAC2	2.05e-04	198	62	5	576_DN
Drug	Hexestrol [84-16-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A	ABLIM1 MICALL2 UBE4B NUCB1 GAS8	2.05e-04	198	62	5	6252_DN
Drug	Benzylpenicillin sodium [69-57-8]; Up 200; 11.2uM; HL60; HT_HG-U133A	TMC7 MAP1A LZTS3 NF2 CEP164	2.10e-04	199	62	5	6155_UP
Drug	Isopropamide iodide [71-81-8]; Down 200; 8.4uM; PC3; HT_HG-U133A	NF2 MYO6 NUCB1 DGCR8 CEP164	2.10e-04	199	62	5	7133_DN
Drug	Reserpine [50-55-5]; Up 200; 6.6uM; HL60; HT_HG-U133A	PPP4R3B ABLIM1 GAS8 DGCR8 CCDC181	2.10e-04	199	62	5	3003_UP
Drug	Fluoxetine hydrochloride [59333-67-4]; Down 200; 11.6uM; HL60; HT_HG-U133A	LZTS3 NF2 MYO7A MFN2 KAT6B	2.14e-04	200	62	5	2453_DN
Drug	PF-00562151-00 [351320-12-2]; Down 200; 10uM; PC3; HT_HG-U133A	TMC7 NF2 DGCR8 ANKRD40 CEP164	2.14e-04	200	62	5	6907_DN
Disease	Autosomal dominant nonsyndromic hearing loss	MYH9 MYO6 MYO7A	2.67e-05	29	59	3	cv:C5779548
Disease	sensorineural hearing loss (is_implicated_in)	MYH9 MYO6 MYO7A	3.97e-05	33	59	3	DOID:10003 (is_implicated_in)
Disease	Hereditary hearing loss and deafness	MYH9 NF2 MYO6 MYO7A	2.12e-04	146	59	4	cv:C0236038
Disease	Nonsyndromic genetic hearing loss	MYH9 MYO6 MYO7A	4.81e-04	76	59	3	cv:C5680182
Disease	proprotein convertase subtilisin/kexin type 7 measurement	BUD13 CEP164	5.24e-04	17	59	2	EFO_0008270
Disease	pain	SUPT3H NOP14 MAD1L1 TRPM8	6.46e-04	196	59	4	EFO_0003843
Disease	serum non-albumin protein measurement	MIA3 NF2 POLR2A AFDN TNIP1	7.77e-04	361	59	5	EFO_0004568
Disease	apolipoprotein L1 measurement	MYH9 DHX38	1.14e-03	25	59	2	EFO_0021854
Disease	Ciliopathies	MYO7A PKD2 CEP164	1.41e-03	110	59	3	C4277690
Disease	Drug habituation	ABLIM1 MYO6 MYO5C	1.60e-03	115	59	3	C0013170
Disease	Substance-Related Disorders	ABLIM1 MYO6 MYO5C	1.60e-03	115	59	3	C0236969
Disease	Drug abuse	ABLIM1 MYO6 MYO5C	1.60e-03	115	59	3	C0013146
Disease	Drug Use Disorders	ABLIM1 MYO6 MYO5C	1.60e-03	115	59	3	C0013222
Disease	Drug Dependence	ABLIM1 MYO6 MYO5C	1.60e-03	115	59	3	C1510472
Disease	Substance Dependence	ABLIM1 MYO6 MYO5C	1.60e-03	115	59	3	C0038580
Disease	Substance Use Disorders	ABLIM1 MYO6 MYO5C	1.60e-03	115	59	3	C0038586
Disease	Organic Mental Disorders, Substance-Induced	ABLIM1 MYO6 MYO5C	1.60e-03	115	59	3	C0029231
Disease	Prescription Drug Abuse	ABLIM1 MYO6 MYO5C	1.60e-03	115	59	3	C4316881
Disease	Substance abuse problem	ABLIM1 MYO6 MYO5C	1.64e-03	116	59	3	C0740858

Protein segments in the cluster

Peptide	Gene	Start	Entry
LEEMRKREAEDRARQ	AFDN	1616	P55196
IDDEDLDRMLREQER	BUD13	526	Q9BRD0
DMKRRSSGREEDDEE	ABLIM1	581	O14639
EEELARIREEEGMRR	CCDC77	371	Q9BR77
RREIRKIMGVEEEDD	ANKRD40	86	Q6AI12
QEEMKRLAEEREETR	DGCR8	736	Q8WYQ5
DLIDVREVMERDAKD	RAB22A	121	Q9UL26
EKEAEREEERRREMA	RBM25	476	P49756
RLRDREKEMEADERD	RBM25	521	P49756
ADERDRKREKEELEE	RBM25	531	P49756
DDIRRMEEETKRQLD	PITPNA	241	Q00169
TEEERKRRIEQDMLE	NEXN	121	Q0ZGT2
KLSFEEMERQRREDE	NEXN	311	Q0ZGT2
KEEDLLRENSMLREE	POTEB2	481	H3BUK9
EREAEKEAERLMEQA	KAT6B	1001	Q8WYB5
ARQDLEAMRRRKEEE	DAAM2	971	Q86T65
RREQELAEREMDIVE	MAP3K10	421	Q02779
EEMKREERALLAEQR	MAP1A	536	P78559
EAARLMRQREELEDK	LZTS3	406	O60299
EEEKRMLEAQLERRA	MAD1L1	516	Q9Y6D9
VERLREQEEDKEMAD	BMERB1	136	Q96MC5
DRLREQEEDQMLRDM	MICALL2	861	Q8IY33
MLEGEQEEERKRELE	PDCD7	376	Q8N8D1
EQDERLREKEERMRE	GOLGA6L2	401	Q8N9W4
DQEEKMQEEERIRER	GOLGA6L2	441	Q8N9W4
VREMEAELEDERKQR	MYH9	1591	P35579
RFRRDAKALEEDEEM	PPP4R3B	701	Q5MIZ7
NEEDDMREMEEERLR	NUCB1	281	Q02818
AERLRRMLGKDEDEN	NOP14	291	P78316
EEMREERQDRLKFID	MFN2	391	O95140
EDIRRMEDETQKELE	PITPNB	241	P48739
REKQMREEAERTRDE	NF2	341	P35240
EEEEDEEVRRYIMEK	CCDC181	116	Q5TID7
RRAEEQMLKEREERE	EIF3A	816	Q14152
VDEEEEAVEERRNMR	POLQ	846	O75417
ERDKRMREEQLAREA	MAP7D1	626	Q3KQU3
EDRARLEQMTEKERE	RTF1	191	Q92541
QDARDKMEDIERQVR	SMC3	261	Q9UQE7
RRIEEMEDELQKTER	MIA3	1571	Q5JRA6
KEEDLLRENSMLREE	POTEB	481	A0A0A6YYL3
REEEERRMEEQRKAA	PRRC2C	466	Q9Y520
KRITNDAREDEMEEN	SNAP23	141	O00161
AEERERMREEEKRAA	CALD1	311	Q05682
EEEEARMREEESQRL	CEP164	656	Q9UPV0
ERSDRERMNEEKEEL	TNIP1	476	Q15025
YEKRQEEEEAMRRER	YTHDF3	566	Q7Z739
DDEIDEVKQERMERA	SUPT3H	156	O75486
FAGDIEEMEERREKR	ELAC2	771	Q9BQ52
MEKEEDERLLEGDRE	RNF112	611	Q9ULX5
MERMKRLQEEREDEE	SESN3	266	P58005
LRELNEKLMEEREED	STYXL2	271	Q5VZP5
ELEREFERMREDREV	POLR2A	951	P24928
IENMEVDENDRREKR	UBE4B	126	O95155
EDRAARLDRKMEEQQ	SMC6	301	Q96SB8
NRRRAKEEASAMEEE	DHX38	1161	Q92620
QQMRDDLEKEREDLD	PKD2	776	Q13563
EEELEAERAMRAKIE	MYH16	311	Q9H6N6
RKEDRNGRDEMDIEL	TRPM8	536	Q7Z2W7
VALERRREQEEKEDM	WNK4	146	Q96J92
ADLEEERMRQKIAER	TMC7	336	Q7Z402
DFEERMKELREEEEK	ZMAT2	141	Q96NC0
ELRNKDREMEEAEER	GAS8	76	O95995
DQDDEEARREMARIL	SLC8A1	316	P32418
ENRDLEEELDMKDRV	MYO5C	1316	Q9NQX4
EEAERLRRIQEEMEK	MYO6	921	Q9UM54
ERGRREMVEEDLDAA	MYO7A	971	Q13402
LKELARERENMDTDD	NMD3	421	Q96D46